EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Long-Term Treatment for Laron Syndrome with IGF-1 Injection over 22 Years in Saudi Arabia: A Cohort Study

Abdullah Ali Alashwal, Areej Al-Fattani, Khushnooda Ramzan, Faiqa Imtiaz, Amal Binladen

Hormone Research in Paediatrics · 2024

DOI: 10.1159/000543047 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Abdullah Ali Alashwal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Laron Syndrome, Insulin-Like Growth Factor I. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Laron syndrome (LS) is a rare autosomal recessive disorder caused by mutations in the growth hormone (GH) receptor gene, resulting in GH resistance and reduced levels of insulin-like growth factor 1 (IGF-1). Patients with LS exhibit severe growth retardation, low IGF-1 levels, elevated basal GH, and poor response to GH stimulation. Recombinant IGF-1 is the only approved treatment and has been shown to improve linear growth. This study evaluates the long-term efficacy and safety of IGF-1 therapy in a large cohort of LS patients treated at King Faisal Specialist Hospital and Research Center (KFSH & RC), Riyadh, Saudi Arabia over 22 years.

Methods

We conducted a retrospective review of medical records for 28 patients with growth hormone insensitivity syndrome, including 12 males and 16 females, treated with IGF-1 from 1998 to 2020. Patients were selected based on criteria including age over 2 years, height standard deviation score (SDS) ≤−2.8, normal or elevated GH secretion (>2.5 ng/mL), IGF-1 levels

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laron SyndromeInsulin-Like Growth Factor IHumansMaleFemaleChildSaudi ArabiaRetrospective StudiesAdolescentChild, PreschoolCohort StudiesBody Height

Stichwörter der Autor:innen

GHR mutationGrowth hormone insensitivityGrowth hormone receptorGrowth retardationHeightHeight velocityInsulin-like growth factor-1 treatmentLaron syndromeLong-term follow-up

Substanzen

Insulin-Like Growth Factor IIGF1 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Department of Biostatistics Epidemiology and Scientific computing, King Faisal Specialist Hospital and Research Hospital, Riyadh, Saudi Arabia.
  • Department Clinical Genomics, Centre for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, amal.bin@hotmail.com.

Zitieren

APA

Alashwal, A. A., Al-Fattani, A., Ramzan, K., Imtiaz, F., & Binladen, A. (2024). Long-Term Treatment for Laron Syndrome with IGF-1 Injection over 22 Years in Saudi Arabia: A Cohort Study. Hormone Research in Paediatrics. https://doi.org/10.1159/000543047

Vancouver

Alashwal AA, Al-Fattani A, Ramzan K, Imtiaz F, Binladen A. Long-Term Treatment for Laron Syndrome with IGF-1 Injection over 22 Years in Saudi Arabia: A Cohort Study. Hormone Research in Paediatrics. 2024. doi:10.1159/000543047

BibTeX
@article{Alashwal2024,
  author = {Alashwal, Abdullah Ali and Al-Fattani, Areej and Ramzan, Khushnooda and Imtiaz, Faiqa and Binladen, Amal},
  title = {Long-Term Treatment for Laron Syndrome with IGF-1 Injection over 22 Years in Saudi Arabia: A Cohort Study},
  journal = {Hormone Research in Paediatrics},
  year = {2024},
  doi = {10.1159/000543047}
}
Kostenlos starten →